Alteração de nome deferida
#25.4
05/12/2026
RPI 2888
Application data
Number
112025004088Type
Filing
Publication
PCT
US2023031925 Examination has not been requested yet. Without that request by 09/02/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:09/02/2026(8 days left)
Latest action published by the INPI: 05/12/2026. We update with every new RPI gazette, published weekly.
Applicants
CREATE MEDICINES, INC.
US
MYELOID THERAPEUTICS, INC.
US
Inventors
D. G. (pessoa física)
US
N. D. (pessoa física)
US
Y. W. (pessoa física)
US
IPC Classification
Priority claims
US
63/403,449 · 09/02/2022
US
63/403,454 · 09/02/2022
US
63/403,455 · 09/02/2022
Abstract
COMPOSIÇÕES PARA EXPRESSÃO ESPECÍFICA DE CÉLULA E USOS DAS MESMAS. Composições e métodos para produzir e utilizar células NK, células T e células B modificadas que expressam um receptor de antígeno quimérico.
Publications in the Brazilian Industrial Property Gazette (RPI).
#25.4
05/12/2026
RPI 2888
#1.3
09/02/2025
RPI 2852
#1.1
03/11/2025
RPI 2827
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.